REDDING, Calif., June 25, 2024 /PRNewswire/ -- According to a new
market research report, 'Defibrillator Market by
Product (Implantable (ICD) [Transvenous {Dual Chamber,
Single-chamber, CRT-D}, Subcutaneous], External (ECD) [Manual,
Automated, Wearable]), End User (Hospital, Emergency Care, Home
Care), Age Group - Global Forecast to 2031', published by
Meticulous Research®, the defibrillator market is
projected to reach $22.76 billion by
2031, at a CAGR of 6.9% from 2024 to 2031.
Download Sample Report Now-
https://www.meticulousresearch.com/download-sample-report/cp_id=3596
Cardioverter defibrillators are devices that detect and control
heartbeats, also known as arrhythmia, and deliver electric shocks
to restore a regular heart rhythm.
The growth of the defibrillator market is driven by several
factors, including the increasing burden of cardiovascular diseases
and the rise in obesity, sedentary lifestyle, and excessive
consumption of alcohol & caffeinated products, and the rising
geriatric population. Advancements in technology and engineering
offer clinicians & surgeons new ways to provide better care for
an aging population with ease. A few notable and innovative
advancements in cardioverter defibrillator devices include
miniaturization, magnetic resonance imaging (MRI) compatibility,
outstanding longevity with enhanced battery life, wireless remote
monitoring features, and innovative subcutaneous cardioverter
defibrillators.
The report also includes an extensive assessment of the product
portfolio, geographic analysis, and key growth strategies adopted
by leading market players in the last three to four years. In
recent years, the defibrillator market has witnessed several
organic and inorganic strategic developments. The key players
profiled in the defibrillator market report are Medtronic plc
(Ireland), Boston Scientific
Corporation (U.S.), Abbott Laboratories (U.S.), Biotronik Se &
Co., Kg (Germany), LivaNova plc
(U.K.), Stryker Corporation (U.S.), Koninklijke Philips N.V.
(Netherlands), Nihon Kohden
Corporation (Japan), Progetti Srl
(Italy), Fukuda Denshi Co., Ltd.
(Japan), Schiller AG (Switzerland), and ZOLL Medical Corporation
(U.S.).
Rise in Obesity, Sedentary Lifestyle, & Excessive
Consumption of Alcohol & Caffeinated Products is Increasing the
Need for Defibrillators and Driving the Growth of the
Market
The increasing urbanization and mechanization of the world have
reduced the levels of physical activity. According to the World
Health Organization (WHO), in 2022, 27.5% of the world's adult
population did not meet the recommended level of physical activity
to improve and manage their health. According to the World Health
Federation, physical activity is considered a life-boosting factor,
and thereby, at any age, it protects against multiple chronic
health problems, including many forms of cardiovascular diseases.
As per the American Heart Association (AHA), an adult should carry
out at least 150 minutes of exercise per week to reduce the risk of
cardiovascular diseases. Thus, rising urbanization and the rising
trend of a sedentary work culture increase the proportion of the
population with no or very low physical activity, thereby
increasing the risk of occurrence of severe cardiovascular
diseases.
Get a Glimpse Inside: Request Sample Pages-
https://www.meticulousresearch.com/request-sample-report/cp_id=3596
In addition to this, the rising burden of secondary health
conditions/diseases such as obesity and diabetes are major factors
contributing to the risk of cardiovascular diseases. According to
the International Diabetes Federation (IDF), globally, in 2021,
approximately 537 million adults were living with diabetes, which
is projected to rise to 643 million by 2030 and 783 million by
2045. The risk of type 2 diabetes and hypertension has registered a
steep increase in the overweight population. With increasing levels
of obesity and physical inactivity among children in many
countries, type 2 diabetes in childhood has the potential to become
a public health issue, leading to serious health outcomes.
Also, increasing consumption of tobacco and alcohol, along with
caffeinated products, are responsible for the elevated risk of
cardiovascular disorders. According to the National Institutes of
Health, alcohol can be beneficial or harmful to the cardiovascular
system, depending on the amount consumed. Although
light-to-moderate drinking can protect against coronary artery
disease, heavy alcohol consumption can damage the cardiovascular
system, resulting in health conditions such as heart muscle
disorders, irregular heart rhythms, high blood pressure, and
strokes.
Thus, rising adoption of a sedentary lifestyle, increasing rates
of obesity & diabetes, and rising consumption of excessive
alcohol & tobacco are increasing the risk of cardiovascular
diseases among the young population across the globe. These
conditions are also leading to a rise in severe cardiac arrest
& related deaths in the young population and, thereby,
increasing the demand for defibrillators in high-risk
populations.
The defibrillator market is segmented by Product (Implantable
Cardioverter Defibrillators [Transvenous Implantable Cardioverter
Defibrillators {Cardiac Resynchronization Therapy Defibrillators
(CRT-D), Dual-Chamber Implantable Cardioverter Defibrillators,
Single-chamber Implantable Cardioverter Defibrillators},
Subcutaneous Implantable Cardioverter Defibrillators], External
Cardiac Defibrillators [Manual ECD, Automated ECD {Semi-automated
ECD, Fully-automated ECD}, Wearable ECD), Age Group (Adult,
Children), End User (Hospital and Ambulatory Surgery Centers, Pre
Hospital/Emergency Care, Public Access Programs,
Alternative/Foster Care, and
Homecare), and Geography.
Have Specific Research Needs? Request a Customized
Report-
https://www.meticulousresearch.com/request-customization/cp_id=3596
Among all products, in 2024, the implantable cardioverter
defibrillators segment is expected to account for the largest share
of the market. Implantable cardioverter defibrillators are small
battery-powered devices that are used to detect, stop, and regulate
irregular heartbeats. These irregular heartbeats, also known as
arrhythmias, are restored by delivering electric shocks to the
heart. The large share of the segment is attributed to features
such as wide adoption of permanent implantable cardioverter
defibrillators for the prevention of sudden cardiac arrests,
increase in the incidences of cardiac arrests and atrial
fibrillation, growing use of modern technologies for treatment, and
growing awareness towards healthcare. For instance, according to
the Centers for Disease Control and Prevention (CDC), more than
356,000 people have an out-of-hospital cardiac arrest in the U.S.
every year, and approximately 60-80% die before reaching the
hospital. Due to this, the need and demand for defibrillators
increases.
Among age groups, in 2024, the adult segment is expected to
account for the larger share of the market. The large share of the
segment is attributed to factors such as higher occurrence of
ventricular fibrillation (VF) in adults, higher rates of cardiac
arrest as compared to children, increasing cardiovascular
conditions, and technological advancements in defibrillator
devices. In the case of ventricular fibrillation, the lower heart
chambers contract rapidly in an uncoordinated manner. Owing to
this, the heart fails to pump blood to the rest of the body.
Ventricular fibrillation (VF) is the most frequent cause of sudden
cardiac death. The incidence of VF is much lower in adults compared
to the pediatric population, owing to which the demand for
defibrillators is higher for this age group.
Among end users, in 2024, the hospitals segment is expected
to account for the largest share of the market. The large
share of the segment is attributed to factors such as the large
pool of cardiovascular patients, wide presence, easy accessibility,
and better healthcare facilities in hospitals, increasing incidence
& prevalence of cardiovascular diseases such as hypertension,
bradycardia, heart failure, and cardiac arrest, and the rise in the
aging population. The number of hospital admissions for heart
disease is increasing each year. For instance, according to the
Minnesota Department of Health (U.S.), in 2021, there were more
than 46,000 hospitalizations in Minnesota for heart diseases, or at a rate of
668 hospitalizations per 100,000 people. The use of an ICD in
certain heart conditions lowers the risk of sudden deaths due to
cardiac arrest and also detects and regulates irregular heartbeats
or arrhythmia. This, along with the rising geriatric population and
high burden of cardiovascular diseases, is expected to increase the
volume of defibrillator implantations in hospitals, supporting the
growth of the market.
Among geographies, Asia-Pacific
is slated to register the highest CAGR of the market. The high
growth of the segment is primarily due to the increasing population
living with various chronic diseases due to rising urbanization,
increasing burden of patients with hypertension, rising inclination
towards fast food, and changing lifestyle. In addition, rising
public & private spending for the development of proper
healthcare infrastructure and rising focus of the key players
to expand in emerging countries like China & India. According to data released by the
National Crime Records Bureau (NCRB), 32,457 individuals suffered
heart attacks in 2022 as compared to 28,413 deaths in 2021.
Currently, India is the largest
importer of cardioverter defibrillators worldwide and imports these
devices from the U.S., China,
France, and Ireland. These devices are easily accessible
due to their portability and can be used in case of emergencies
such as a sudden cardiac arrest. This importation is leading the
key players to expand in developing countries such as India, therefore driving the demand for
defibrillators.
Browse In-depth Report Now-
https://www.meticulousresearch.com/product/defibrillator-market-3596
Scope of the Report:
Defibrillator Market—by Product
- Implantable Cardioverter Defibrillators
-
- Transvenous Implantable Cardioverter Defibrillators
-
- Cardiac Resynchronization Therapy Defibrillators (CRT-D)
- Dual-chamber Implantable Cardioverter Defibrillators
- Single-chamber Implantable Cardioverter Defibrillators
- Subcutaneous Implantable Cardioverter Defibrillators
- External Cardioverter Defibrillators
-
- Manual ECD
- Automated ECD
-
- Semi-automated ECD
- Fully-automated ECD
- Wearable ECD
Defibrillator Market—by Age Group
Defibrillator Market—by End User
- Hospital and Ambulatory Surgery Centers
- Pre-Hospital/Emergency Care
- Public Access Programs
- Alternative/Foster Care
- Homecare
Unlock Opportunities: Buy Now-
https://www.meticulousresearch.com/Checkout/76718964
Related Reports:
Cardiac Pacemaker Devices Market by Product (Cardiac
Pacemaker, Implantable Pacemakers, [Dual Chamber, CRT Pacemaker],
External Pacemaker, Pacing Leads), Indication (Arrhythmia, CHF),
End User (Hospital & Clinics, Ambulatory Care Centers) -
Forecast to 2028
Surgical Robots Market by Product & Service (Surgical
Instruments & Accessories, Robotic Systems, Services),
Application (Orthopedic, Obstetrics & Gynecological,
Cardiovascular & Thoracic, Urology, General Surgery), End User
- Global Forecast to 2030
Wearable Medical Devices Market by Type (Smart Watch, Activity
Monitor, Patch), Application (Monitoring {Glucose, BP, Sleep, RPM},
Therapeutic {Pain, Rehabilitation, Insulin), Grade (Consumer,
Medical), Distribution Channel – Global Forecast to 2030
IoT in Healthcare Market by Component (Monitoring Devices
(Glucose, Cardiac, Respiratory, Blood Pressure), Pacemaker,
Ventilator, Infusion Pump}, Software), Application (Telehealth,
Imaging, Operation Management), End User - Global Forecast to
2030
Peripheral Vascular Devices Market by Type [Angioplasty
Balloon, Stents, Catheters (Guiding, IVUS), IVC Filter,
Atherectomy, Thrombectomy, Hemodynamic Flow Alteration (Embolic
Protection, Occlusion)] and Geography - Global Forecast to 2028
About Meticulous Research®
Meticulous Research® was founded in 2010 and incorporated as
Meticulous Market Research Pvt. Ltd. in 2013 as a private limited
company under the Companies Act, 1956. Since its incorporation, the
company has become the leading provider of premium market
intelligence in North America,
Europe, Asia-Pacific, Latin
America, and the Middle
East & Africa.
The name of our company defines our services, strengths, and
values. Since the inception, we have only thrived to research,
analyze, and present the critical market data with great attention
to details. With the meticulous primary and secondary research
techniques, we have built strong capabilities in data collection,
interpretation, and analysis of data including qualitative and
quantitative research with the finest team of analysts. We design
our meticulously analyzed intelligent and value-driven syndicate
market research reports, custom studies, quick turnaround research,
and consulting solutions to address business challenges of
sustainable growth.
Contact:
Mr. Khushal Bombe
Meticulous Market Research Inc.
1267 Willis St, Ste 200 Redding,
California, 96001, U.S.
USA: +1-646-781-8004
Europe : +44-203-868-8738
APAC: +91 744-7780008
Email- sales@meticulousresearch.com
Visit Our Website: https://www.meticulousresearch.com/
Connect with us on LinkedIn-
https://www.linkedin.com/company/meticulous-research
Content Source:
https://www.meticulousresearch.com/pressrelease/313/defibrillator-market-2031
Logo:
https://mma.prnewswire.com/media/1757980/Meticulous_Research_Logo_1.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/defibrillator-market-to-be-worth-22-76-billion-by-2031---exclusive-report-by-meticulous-research-302181614.html